19:40:22 EDT Tue 28 Apr 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Mustgrow Biologics Corp
Symbol MGRO
Shares Issued 62,959,818
Close 2026-04-28 C$ 0.60
Market Cap C$ 37,775,891
Recent Sedar+ Documents

Mustgrow gets Georgia approval for biofertility product

2026-04-28 16:54 ET - News Release

Mr. Corey Giasson reports

MUSTGROW RECEIVES GEORGIA REGISTRATION FOR TERRASANTE BIOFERTILITY PRODUCT

Mustgrow Biologics Corp. has received the Georgia Department of Agriculture registration approval for its mustard plant-based TerraSante, an organic biofertility product. The Georgia organic certification is included under Mustgrow's existing organic OMRI-listed certifications in Florida, Arizona, Idaho, Oregon and Washington state.

Mustgrow's Georgia registration and organic certification strengthens commercial opportunities as both Florida and Georgia's high-value crop acres are a natural fit for the success TerraSante is currently delivering in California. Mustgrow's TerraSante is already approved for sale in Florida. TerraSante demand is growing in registered states along the West Coast of the U.S..

In 2023, Georgia ranked No. 1 versus other U.S. states in peanuts production ($762-million (U.S.) cash receipts), No. 2 in pecans ($184-million (U.S.) cash receipts) and No. 3 in blueberries ($156-million (U.S.) cash receipts), which may or may not have a direct impact on Mustgrow and its business.

TerraSante for soil and ecological health

Mustgrow's mustard-derived TerraSante organic biofertilizer is a wettable powder containing nutritious plant proteins and carbohydrates that feed the soil and soil microbes, potentially improving beneficial microbial activity and long-term sustainable soil health. TerraSante is currently registered and approved for sale in California, Florida, Georgia, Arizona, Idaho, Oregon, and Washington State, under Organic OMRI Listed certification and California's Organic Input Material (OIM) program.

Mustgrow's biofertility program focuses on soil and soil microbiome health, nutrient and water use efficiencies, and plant yields. Soil is a farmer's most valuable asset, and Mustgrow's mustard plant-based technologies are being applied with the intention to improve the health of the soil and soil microbiome, and have a positive impact on root and plant health. These targeted microcommunities have been shown to work to improve nutrient availability, which can potentially increase plant vigor and yields, while reducing plant stress. TerraSante has the potential to improve crop nutrient uptake and, hence, overall crop performance. There are no artificial additives or preservatives used during its manufacturing.

About Mustgrow Biologics Corp.

Mustgrow Biologics is a provider of innovative biological and regenerative agriculture solutions designed to support sustainable farming. The company's technology is centered on harnessing the natural defence mechanisms and organic compounds found in mustard seed and formulating them into organic biofertility, biostimulant and biocontrol products. These solutions are designed to protect soil health and the soil microbiome, support plant health, and contribute to global food security through more sustainable agricultural practices. In the United States, Mustgrow's flagship biofertility product, TerraSante, is registered, organically certified, and commercially sold in key agricultural states, including California. Outside of North America, Mustgrow is focused on collaborating with leading global agriculture companies, such as Bayer AG in Europe, the Middle East and Africa, to commercialize its wholly owned proprietary products and technologies. The company is dedicated to driving shareholder value through the commercialization and expansion of its intellectual property portfolio, which includes approximately 110 issued and pending patents. Mustgrow is publicly traded on the TSX Venture Exchange under the symbol MGRO and has approximately 63.0 million common shares issued and outstanding, and approximately 76.7 million shares on a fully diluted basis.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.